These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29977767)

  • 1. Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report.
    Storms WW; Miller JE
    Respir Med Case Rep; 2018; 24():84-85. PubMed ID: 29977767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report.
    Singer E; Miller JE
    Respir Med Case Rep; 2019; 26():9-10. PubMed ID: 30450278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection.
    Tripathi S; Nikhare A; Sharma G; Shea T; Albrecht H
    Drug Healthc Patient Saf; 2019; 11():87-94. PubMed ID: 31632154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report.
    Storms WW; Miller JE
    Respir Med Case Rep; 2018; 23():156-157. PubMed ID: 29719806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved quality of life associated with long-term daily use of guaifenesin (Mucinex
    Singer E; Miller JE
    Oxf Med Case Reports; 2018 Sep; 2018(9):omy060. PubMed ID: 30159154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study.
    Septimus EJ; Albrecht HH; Solomon G; Shea T; Guenin EP
    Curr Ther Res Clin Exp; 2017; 84():54-61. PubMed ID: 28761581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
    Albrecht HH; Dicpinigaitis PV; Guenin EP
    Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial examining effectiveness of three cough syrups.
    Croughan-Minihane MS; Petitti DB; Rodnick JE; Eliaser G
    J Am Board Fam Pract; 1993; 6(2):109-15. PubMed ID: 8452062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional capacity (dyspnea) and quality of life in patients with chronic obstructive lung disease (COPD): instruments of assessment and methodological aspects].
    Hütter BO; Würtemberger G
    Pneumologie; 1999 Mar; 53(3):133-42. PubMed ID: 10226475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
    Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
    Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
    Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
    Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cough and mucus on COPD patients: primary insights from an exploratory study with an Online Patient Community.
    Cook N; Gey J; Oezel B; Mackay AJ; Kumari C; Kaur VP; Larkin N; Harte J; Vergara-Muro S; Gutzwiller FS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1365-1376. PubMed ID: 31417250
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.
    Wu CW; Hsieh PC; Yang MC; Tzeng IS; Wu YK; Lan CC
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2543-2551. PubMed ID: 31819392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life changes over time in patients with chronic obstructive pulmonary disease.
    Jones GL
    Curr Opin Pulm Med; 2016 Mar; 22(2):125-9. PubMed ID: 26814143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease.
    Kim V; Zhao H; Boriek AM; Anzueto A; Soler X; Bhatt SP; Rennard SI; Wise R; Comellas A; Ramsdell JW; Kinney GL; Han MK; Martinez CH; Yen A; Black-Shinn J; Porszasz J; Criner GJ; Hanania NA; Sharafkhaneh A; Crapo JD; Make BJ; Silverman EK; Curtis JL;
    Ann Am Thorac Soc; 2016 Jul; 13(7):1016-25. PubMed ID: 27158740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.